Companies, News, Discussion, and Investing.

marijuana News

marijuana

Abattis Files for Injunctive Relief in Washington State and Claims Damages Against Former Employees, Business Associates and Competitor, Affinor Growers, Inc. and Certain of its Associates

Posted In: News| Posted On:Oct 25, 2014 No Comment

Vancouver, BC – October 24, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that it has today, in U.S. Federal court in Washington State, filed suit for damages and injunctive relief against prior employees of PhytaLab (Dr. Kaleb Lund and Ms. Lauren Hilty), a former Read More

Abattis' Announces New Investor Relations Appointment

Posted In: News| Posted On:Oct 16, 2014 No Comment

Vancouver, BC — October 17, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that they have entered Read More

Abattis Announces Zoning Approval on the Experion MMPR Application

Posted In: News| Posted On:Oct 08, 2014 No Comment

Vancouver, BC — October 8, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that through its wholly owned subsidiary, Northern Vine Canada Inc. (“Northern Vine”), Read More

Abattis Announces Appointment Guy Dancosse, Q.C. to Board of Directors

Posted In: News| Posted On:Sep 16, 2014 No Comment

Vancouver, BC – September 16, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Guy Dancosse, Q.C. has agreed to join the Board effective immediately Read More

Abattis' Phytalab Receives Cannabis Lab Certification In Washington

Posted In: News| Posted On:Sep 08, 2014 No Comment

Vancouver, BC – September 8th, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Phytalytics LLC. (“Phytalab.com”), Read More

A Moral Case for Investing in Marijuana

Posted In: Blog| Posted On:Aug 31, 2014 No Comment

If you are like me you have been watching the evolution of the marijuana sector with great interest.  What seems like slowly but one day at a time, the use of marijuana both for medical and recreational purposes is being met with wider acceptance.  And while ‘wider’ is an arbitrary term, never did I expect Read More

Licensed Canadian Medical Marijuana Producers List

Posted In: Blog| Posted On:Aug 30, 2014 No Comment

As of August 26th, 2014, 13 Canadian Companies are now licensed producers authorized to sell or provide marijuana to eligible persons under the Canadian Marihuana for Medical Purposes Regulations (MMPR).  We present the following in no particular order: Tweed – www.tweed.com  Organigram – www.organigram.ca Bedrocan – www.bedrocan.ca In the Zone – www.inthezoneproduce.ca Delta 9 – Read More

OrganiGram Announces Closing of Reverse Takeover and Concurrent Financings for $7.5 Million

Posted In: News| Posted On:Aug 25, 2014 No Comment

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Aug. 25, 2014) - OrganiGram Holdings Inc. (TSX VENTURE:OGI) (formerly, Inform Exploration Corp.) (TSX VENTURE:IX) (the “Company” or “Inform“) is pleased to announce that it has, effective August 22, 2014, completed its acquisition (the “Acquisition“) of all of the issued and outstanding securities of OrganiGram Inc. (“OGI“), a New Brunswick licensed producer of Read More

Bedrocan Cannabis Corp. (formerly POCML 2 Inc.) completes Qualifying Transaction; Resulting Issuer Expected to Commence Trading August 25, 2014

Posted In: News| Posted On:Aug 25, 2014 No Comment

TORONTO, Aug. 21, 2014 - Bedrocan Cannabis Corp. (formerly POCML 2 Inc.) (TSX-V: BED) (the “Corporation”) is pleased to announce that it has completed its qualifying transaction (the “Qualifying Transaction”) with Bedrocan Canada Inc. (“Bedrocan”), as previously announced in its press releases dated April 14 and May 15, 2014. In connection with the Qualifying Transaction and prior to closing, the Corporation Read More

Bedrocan Cannabis Corp. – tsx.v: BED

Posted In: Company Profile, News| Posted On:Aug 25, 2014 No Comment

 Bedrocan Cannabis Corp. – tsx.v: BED source: www.bedrocan.com Bedrocan is the most experienced, research-centered producer of pharmaceutical-grade medicinal cannabis in the world, with a mission to provide patients and healthcare professionals with safe, effective and consistent medicine for the appropriate management of diagnosed health conditions.   Bedrocan Experience   Bedrocan is the global leader in Read More


Directory powered by Business Directory Plugin